Prevalence of CKD, Diabetes, and Hypertension in Rural Tanzania

Kidney International Reports

Volumn 3, Issue 4, 2018, Pages 905-915

  Ploth, David W ^a   Mbwambo, Jessie K ^b   Fonner, Virginia A ^a   Horowitz, Bruce ^c   Zager, Phillip ^d   Schrader, Ron ^d   Fredrick, Francis ^b   Laggis, Caroline ^c   Sweat, Michael D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

diabetes mellitus; hypertension; kidney disease; prevalence; Tanzania

Indexed keywords

EID: 85049096098     PISSN: 24680249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ekir.2018.04.006     Document Type: Article

References (42)

1. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
2. Hill, N.R., Fatoba, S.T., Oke, J.L., et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One, 11, 2016, e0158765.
3. Kearney, P.M., Whelton, M., Reynolds, K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005), 217–223.
4. Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF Diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Practice 94 (2011), 311–321.
5. Stanifer, J.W., Maro, V., Egger, J., et al. The epidemiology of chronic kidney disease in northern Tanzania: a population-based survey. PLoS One, 10, 2015, e0124506.
6. Janmohamed, M.N., Kalluvya, S.E., Mueller, A., et al. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol 14 (2013), 1–5.
7. Pickering, T.G., Hall, J.E., Appel, L.J., et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 111 (2005), 697–716.
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33:suppl 1 (2010), S62–S69.
9. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. 2011, World Health Organization, Geneva.
10. Peake, M., Whiting, M., Measurement of serum creatinine—current status and future goals. Clin Biochem Rev 27 (2006), 173–184.
11. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150 (2009), 604–612.
12. Inker, L.A., Astor, B.C., Fox, C.H., et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63 (2014), 713–735.
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:2 suppl 1 (2002), S1–S266.
14. R: A language and environment for statistical computing [computer program], 2016, Foundation for Statistical Computing, Vienna, Austria Available at: https://www.R-project.org/.
15. Stata Statistical Software [computer program], 2015, StataCorp LP, College Station, TX.
16. Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb Mortal Wkly Rep 56 (2007), 161–165.
17. Inker, L.A., Shafi, T., Okparavero, A., et al. Effects of race and gender on measured GFR: the multi-ethnic study of atherosclerosis. Am J Kidney Dis 68 (2016), 743–751.
18. Stanifer, J.W., Jing, B., Tolan, S., et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2 (2014), e174–e181.
19. Stanifer, J.W., Egger, J.R., Turner, E.L., et al. Neighborhood clustering of non-communicable diseases: results from a community-based study in northern Tanzania. BMC Public Health, 16, 2016, 226.
20. USRDS Report: Incidence, prevalence, patient characteristics, & treatment modalities. Am J Kidney Dis 63 (2014), e215–e228.
21. Mpondo, B.C.T., Neilson, E., Ernest, A., Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrology, 17, 2016, 71.
22. Kavishe, B., Biraro, S., Baisley, K., et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in northwestern Tanzania and southern Uganda. BMC Med, 13, 2015, 126.
23. Hendriks, M.E., Wit, F.W., Roos, M.T., et al. Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities. PLoS One, 7, 2012, e32638.
24. Galson, S.W., Staton, C.A., Karia, F., et al. Epidemiology of hypertension in northern Tanzania: a community-based mixed-methods study. BMJ Open, 7, 2017, e018829, 10.1136/bmjopen-2017-018829.
25. Yoon, S.S., Carroll, M.D., Fryar, C.D., Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief 220 (2015), 1–8.
26. Stanifer, J.W., Cleland, C.R., Makuka, G.J., et al. Prevalence, risk factors, and complications of diabetes in the Kilimanjaro region: a population-based study from Tanzania. PLoS One, 11, 2016, e0164428.
27. Mayega, R.W., Guwatudde, D., Makumbi, F.E., et al. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Res Clin Pract 104 (2014), 112–120.
28. Gallagher, E.J., Le Roith, D., Bloomgarden, Z., Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 1 (2009), 9–17.
29. Nitin, S., HbA1c and factors other than diabetes mellitus affecting it. Singapore Med J 51 (2010), 616–622.
30. Lacy, M.E., Wellenius, G.A., Sumner, A.E., et al. Association of sickle cell trait with hemoglobin A1c in African Americans. JAMA 317 (2017), 507–515.
31. Coresh, J., Astor, B.C., Greene, T., et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003), 1–12.
32. Coresh, J., Selvin, E., Stevens, L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007), 2038–2047.
33. Barsoum, R.S., Chronic kidney disease in the developing world. N Engl J Med 354 (2006), 997–999.
34. Kupferman, J., Amador, J.J., Lynch, K.E., et al. Characterization of Mesoamerican nephropathy in a kidney failure hotspot in Nicaragua. Am J Kidney Dis 68 (2016), 716–725.
35. Lunyera, J., Mohottige, D., Isenburg, M.V., et al. CKD of uncertain etiology: a systematic review. Clin J Am Soc Nephrol 11 (2016), 379–385.
36. Shepherd, J., Warner, M.H., Kilpatrick, E.S., Stability of creatinine with delayed separation of whole blood and implications for eGFR. Ann Clin Biochem 44 (2007), 384–387.
37. Stevens, L.A., Claybon, M.A., Schmid, C.H., et al. Evaluation of the CKD-EPI equation in multiple races and ethnicities. Kidney Int 79 (2011), 555–562.
38. Agoons, D.D., Balti, E.V., Kaze, F.F., et al. Performance of three glomerular filtration rate estimation equations in a population of sub-Saharan Africans with type 2 diabetes. Diabet Med 33 (2016), 1291–1298.
39. Wyatt, C.M., Schwartz, G.J., Owino Ong'or, W., et al. Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS One, 8, 2013, e69601.
40. Samra, M., Abcar, A.C., False estimates of elevated creatinine. Permanente J 16 (2012), 51–52.
41. Peck, R., Mghamba, J., Vanobberghen, F., et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health 2 (2014), e285–e292.
42. Jha, V., Garcia-Garcia, G., Iseki, K., et al. Chronic kidney disease: global dimension and perspectives. Lancet 382 (2013), 260–272.